Eugene J. Trybulski

1.6k total citations
52 papers, 1.1k citations indexed

About

Eugene J. Trybulski is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eugene J. Trybulski has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 28 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eugene J. Trybulski's work include Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Estrogen and related hormone effects (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Eugene J. Trybulski is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Estrogen and related hormone effects (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Eugene J. Trybulski collaborates with scholars based in United States, Canada and Australia. Eugene J. Trybulski's co-authors include Joseph J. Tufariello, G. B. MULLEN, Shaikh A. Ali, Paige E. Mahaney, E. J. Corey, Robert J. Steffan, Douglas C. Harnish, Peter Sheldrake, K. C. Nicolaou and John R. Falck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Eugene J. Trybulski

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene J. Trybulski United States 19 698 384 112 107 91 52 1.1k
Michael E. Garst United States 21 798 1.1× 394 1.0× 64 0.6× 188 1.8× 72 0.8× 75 1.5k
Methvin Isaac Canada 20 543 0.8× 604 1.6× 65 0.6× 59 0.6× 251 2.8× 42 1.2k
John H. Dodd United States 23 849 1.2× 585 1.5× 50 0.4× 176 1.6× 53 0.6× 53 1.4k
Eckhard Ottow Germany 14 386 0.6× 318 0.8× 55 0.5× 81 0.8× 106 1.2× 31 676
Torsten Knieß Germany 23 538 0.8× 429 1.1× 95 0.8× 252 2.4× 55 0.6× 83 1.4k
Mario Paglialunga Paradisi Italy 20 420 0.6× 641 1.7× 52 0.5× 36 0.3× 173 1.9× 76 1.0k
Elena Carceller Spain 18 374 0.5× 283 0.7× 53 0.5× 72 0.7× 27 0.3× 42 828
Puwen Zhang United States 21 966 1.4× 381 1.0× 269 2.4× 116 1.1× 150 1.6× 46 1.5k
Toshio Izawa Japan 17 745 1.1× 473 1.2× 65 0.6× 92 0.9× 23 0.3× 59 1.2k
Janet Sredy United States 18 548 0.8× 623 1.6× 50 0.4× 111 1.0× 33 0.4× 30 1.4k

Countries citing papers authored by Eugene J. Trybulski

Since Specialization
Citations

This map shows the geographic impact of Eugene J. Trybulski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene J. Trybulski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene J. Trybulski more than expected).

Fields of papers citing papers by Eugene J. Trybulski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene J. Trybulski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene J. Trybulski. The network helps show where Eugene J. Trybulski may publish in the future.

Co-authorship network of co-authors of Eugene J. Trybulski

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene J. Trybulski. A scholar is included among the top collaborators of Eugene J. Trybulski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene J. Trybulski. Eugene J. Trybulski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fensome, Andrew, Joel Goldberg, Casey C. McComas, et al.. (2010). Structure–activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores. Bioorganic & Medicinal Chemistry Letters. 20(5). 1555–1558. 7 indexed citations
2.
Vu, A. T., Puwen Zhang, Paige E. Mahaney, et al.. (2010). 1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as Potent and Selective Norepinephrine Reuptake Inhibitors. Journal of Medicinal Chemistry. 53(5). 2051–2062. 19 indexed citations
3.
Mahaney, Paige E., Christine Huselton, Eugene A. Terefenko, et al.. (2009). Structure–activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(19). 5807–5810. 12 indexed citations
4.
Moore, William, Jeffrey C. Kern, Ramesh A. Bhat, et al.. (2009). Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: Part II. Bioorganic & Medicinal Chemistry. 18(1). 190–201. 18 indexed citations
5.
Manas, Eric S., Robert McDevitt, Yanfang Li, et al.. (2009). Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles. Bioorganic & Medicinal Chemistry. 17(22). 7802–7815. 29 indexed citations
6.
Kern, Jeffrey C., Eugene A. Terefenko, Eugene J. Trybulski, et al.. (2009). 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators. Bioorganic & Medicinal Chemistry Letters. 19(23). 6666–6669. 10 indexed citations
7.
Mahaney, Paige E., Oliver J. McConnell, Yingru Zhang, et al.. (2009). Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols. Bioorganic & Medicinal Chemistry Letters. 19(17). 5029–5032. 12 indexed citations
8.
Blass, Benjamin E., Andrew Fensome, Eugene J. Trybulski, et al.. (2009). Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia. Journal of Medicinal Chemistry. 52(21). 6531–6534. 16 indexed citations
9.
Vu, A. T., Eugene A. Terefenko, William Moore, et al.. (2009). 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(9). 2464–2467. 18 indexed citations
10.
Zhang, Puwen, Eugene A. Terefenko, Jeffrey C. Kern, et al.. (2007). 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist. Bioorganic & Medicinal Chemistry. 15(20). 6556–6564. 18 indexed citations
11.
Trybulski, Eugene J., et al.. (2007). Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan®. Bioorganic & Medicinal Chemistry Letters. 17(21). 5796–5800. 10 indexed citations
13.
Mahaney, Paige E., A. T. Vu, Casey C. McComas, et al.. (2006). Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines. Bioorganic & Medicinal Chemistry. 14(24). 8455–8466. 30 indexed citations
14.
Steffan, Robert J., Edward Matelan, Mark A. Ashwell, et al.. (2006). Control of Chronic Inflammation with Pathway Selective Estrogen Receptor Ligands. Current Topics in Medicinal Chemistry. 6(2). 103–111. 11 indexed citations
15.
Ashwell, Mark A., et al.. (2005). Substituted 4-hydroxyphenyl sulfonamides as pathway-selective estrogen receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16(4). 854–858. 5 indexed citations
16.
Yao, Jianan, Eugene J. Trybulski, & Gea‐Ny Tseng. (1996). Quinidine preferentially blocks the slow delayed rectifier potassium channel in the rested state.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 856–864. 12 indexed citations
17.
Trybulski, Eugene J., et al.. (1990). Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogs of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5). Journal of Medicinal Chemistry. 33(12). 3190–3198. 13 indexed citations
18.
Fryer, R. Ian, et al.. (1983). The synthesis of 4H‐imidazo[5,1‐c][1,4]benzothiazine derivatives. Journal of Heterocyclic Chemistry. 20(6). 1605–1608. 7 indexed citations
19.
Fryer, R. Ian, W. Leimgruber, & Eugene J. Trybulski. (1982). Quinazolines and 1,4-benzodiazepines. 91. Structure-activity relationship between substituted 2-amino-N-(2-benzoyl-4-chlorophenyl)acetamides and 1,4-benzodiazepinones. Journal of Medicinal Chemistry. 25(9). 1050–1055. 8 indexed citations
20.
Tufariello, Joseph J., et al.. (1979). Synthesis in the tropane class of alkaloids. Pseudotropine and dl-cocaine. Journal of the American Chemical Society. 101(9). 2435–2442. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026